Maris Defeats Biovail

Originally Published In the News March 24, 2008 11:15 AM

David Maris might be the happiest man of Wall Street. Although he left the SellSide long ago, his work on Biovail was top-notch. As we said back in September:

Biovail Corporations (BVF-NYSE) checkered past has included more twists and turns than a good spy thriller. They are dropping out of the lawsuit they filed against 22 research analysts and hedge funds, good news for ex-Bank of America analyst David Maris, whose work was usually top notch. Shareholders have been taken for a wild ride on this stock over the past few years, and the $2 million settlement Biovail will pay should add insult to injury. This stock has always stunk to high heaven, and you can quote us on that 9.10.2007

The good guys win one, nice to see. And company officials are apparently not off the hook yet.

Biovail Corporation (NYSE, TSX: BVF - News News) today announced it has reached a settlement with the U.S. Securities and Exchange Commission (SEC) in respect of an investigation of the Company and certain current and former officers.

Congratulations, David Maris.

Biovail Reaches Settlement With SEC, Provides Update On OSC Investigation
Business Wire

Comments:

<< Back to main